Precision BioSciences

General Information
Business:

 

We are a genome editing company dedicated to improving life through our groundbreaking proprietary genome editing platform, “ARCUS.” We leverage ARCUS in the development of our product candidates, which are designed to treat human diseases and create healthy and sustainable food and agricultural solutions. We believe the versatility and breadth of ARCUS support our ability to develop products across the spectrum of biotechnology.

Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)
Employees: 127
Founded: 2006
Contact Information
Address 302 East Pettigrew St., Suite A-100, Durham, NC 27701, US
Phone Number (919) 314-5512
Web Address http://www.precisionbiosciences.com
View Prospectus: Precision BioSciences
Financial Information
Market Cap $784.5mil
Revenues $10.9 mil (last 12 months)
Net Income $-46.0 mil (last 12 months)
IPO Profile
Symbol DTIL
Exchange NASDAQ
Shares (millions): 7.9
Price range $15.00 - $17.00
Est. $ Volume $126.4 mil
Manager / Joint Managers J.P. Morgan/ Goldman Sachs/ Jefferies/ Barclays
CO-Managers -
Expected To Trade: 3/28/2019
Day: Thursday
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change